| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |